The choice of strategy profile in your pension plan
Overview of the modular strategies of Reichmuth & Co.
A separate strategy for all risk profiles.
WE ARE HAPPY TO ADVISE YOU IN A PERSONAL MEETING
News
Swiss pharmaceutical industry facing political headwinds
The pharmaceutical industry is currently high on Donald Trump’s list of priorities. He wants more production and jobs in the US, as well as lower drug prices. As a means of exerting pressure, he is threatening to impose price caps and introduce tariffs on drugs. These goals are, of course, contradictory, which is causing even more uncertainty.
Market commentary on the US trade conflict with Switzerland
The list of new customs measures against Switzerland, published on the night of Swiss National Day on August 1, came as a surprise. The economic impact of the tariffs is significant.
Lucerne lacks a foundation culture
For the first time, a study shows how differently cantons exempt foundations from taxes. Zurich recently liberalized its practice. How is Lucerne reacting?